Commerzbank Aktiengesellschaft’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q3
Sell
-274,200
Closed -$7.51M 1154
2015
Q2
$7.51M Sell
274,200
-7,400
-3% -$208K 0.04% 265
2015
Q1
$7.52M Buy
+281,600
New +$6.48M 0.05% 281
2013
Q4
Sell
-400,000
Closed -$6.77M 1410
2013
Q3
$6.77M Hold
400,000
0.03% 372
2013
Q2
$6.2M Buy
+400,000
New +$6.66M 0.03% 461

Other funds holding NVO

Commerzbank Aktiengesellschaft's NVO Position: Q1 2020 in Review

Commerzbank Aktiengesellschaft sold out of Novo Nordisk (NVO) in Q1 2020, closing a stake of 153,506 shares — an estimated $4.44M sold.

Commerzbank Aktiengesellschaft first reported a position in NVO in Q2 2013 and held it in 27 quarters. The position peaked at $20M in Q3 2015. 644 funds tracked by Wall St. Rank hold NVO as of Q1 2020.

  • Commerzbank Aktiengesellschaft reported no remaining Novo Nordisk position as of Q1 2020 after selling out during the quarter.
  • Commerzbank Aktiengesellschaft sold 153,506 Novo Nordisk shares in Q1 2020, an estimated $4.44M.
  • Commerzbank Aktiengesellschaft first reported a position in Novo Nordisk in Q2 2013 and held it in 27 quarters.
  • Commerzbank Aktiengesellschaft's Novo Nordisk position peaked at $20M in Q3 2015.
  • 644 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2020.

Based on Commerzbank Aktiengesellschaft's 13F filing for Q1 2020, filed 29 Apr 2020.